Molecular probes and methods of use

US11738099B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11738099-B2
Application numberUS-202117182997-A
CountryUS
Kind codeB2
Filing dateFeb 23, 2021
Priority dateAug 4, 2014
Publication dateAug 29, 2023
Grant dateAug 29, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A molecular probe comprising a linear peptide that includes an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; a contrast agent; and a non-peptide linker that covalently links the peptide to the contrast agent.

First claim

Opening claim text (preview).

Having described the invention, the following is claimed: 1. A molecular probe comprising: a linear peptide that includes an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; a contrast agent selected from at least one of a metal chelating agent or metallofullerene; and a non-peptide linker that covalently links the peptide to the contrast agent, the linker including a carboxamide or a maleimide. 2. The probe of claim 1 , wherein the non-peptide linker is a non-peptide aliphatic or heteroaliphatic linker. 3. The probe of claim 1 , wherein the non-peptide linker includes an alkylene dicarboxamide. 4. The probe of claim 1 , wherein the contrast agent is a magnetic resonance imaging (MRI), positron emission tomography (PET), or single photon emission computed tomography (SPECT) contrast agent. 5. The probe of claim 3 , wherein the contrast agent is a metal chelating agent selected from diethylenetriaminepentaacetate (DTPA), 1,4,7,10-tetraazadodecanetetraacetate (DOTA), 1,4,7,10-tetraazadodecane-1,4,7-triacetate (DO3A), ethylenediaminetetraacetate (EDTA), 1,4,7,10-tetraazacyclotridecanetetraacetic acid (TRITA), 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA), 1,4,7,10-tetraazadodecanetetramethylacetate (DOTMA), 1,4,7,10-tetraazadodecane-1,4,7-tri methylacetate (DO3MA), N,N′,N″,N′″-tetraphosphonatomethyl-1,4,7,10-tetraazacyclododecane (DOTP), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylene methylphosphonic acid) (DOTMP), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylene phenylphosphonic acid) (DOTPP), or N,N′-ethylenedi-L-cysteine. 6. The probe of claim 1 , having the formula: wherein: P 1 is a linear peptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; L 1 is an optional spacer, L 2 is an amino group of the peptide P 1 or the optional spacer if present, and M is a metal selected from the group consisting of Gd +3 , Eu +3 , Tm +3 , Dy +3 , Yb +3 , Mn +2 , Fe +3 , 55 Co, 64 Cu, 67 Cu, 47 Sc, 66 Ga, 68 Ga, 90 Y, 97 Ru, 99 mTc, 111 In, 109 Pd, 153 Sm, 177 Lu, 186 Re, and 188 Re; or salts thereof. 7. The probe of claim 6 , wherein L 1 is selected from at least one of a polyalkyleneoxide, polyvinyl alcohol, polyethylene glycol (PEG), polypropylene glycol (PPG), co-polyethylene-polypropylene glycol, polyoxyethylene (POE), polyurethane, polyphosphazene, polysaccharides, dextran, polyvinylpyrrolidones, polyvinyl ethyl ether, polyacryl amide, polyacrylate, or polycyanoacrylates. 8. The probe of claim 1 , having the formula: wherein: P 1 is a linear peptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; L 2 is an amino group of the peptide P 1 , and M is a metal selected from the group consisting of Gd +3 , Eu +3 , Tm +3 , Dy +3 , Yb +3 , Mn +2 , Fe + , 55 Co, 64 Cu, 67 Cu, 47 Sc, 66 Ga, 68 Ga, 90 Y, 97 Ru, 99 mTc, 111 In, 109 Pd, 153 Sm, 177 Lu, 186 Re, and 188 Re, and n is an integer from 0 to 100; or salts thereof. 9. The probe of claim 1 , wherein the metallofullerene is Gd3N@C80.

Assignees

Inventors

Classifications

  • A61K49/14Primary

    Peptides, e.g. proteins · CPC title

  • Methine dyes, e.g. cyanine dyes · CPC title

  • Peptides, proteins, polyamino acids · CPC title

  • conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11738099B2 cover?
A molecular probe comprising a linear peptide that includes an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9; a contrast agent; and a non-peptide linker that covalently links the peptide to the contrast agent.
Who is the assignee on this patent?
Univ Case Western Reserve
What technology area does this patent fall under?
Primary CPC classification A61K49/14. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).